catalyst acceler
gener line expect evid
inflect second half given commerci
reimburs expans emerg bedrock remain
line quarter expect revenu y/i in-lin
expect repres meaning momentum acceler
see preview us revenu vs mse grew y/i mainli
due increas case volum third straight quarter acceler
slightli off-set revenu vs mse
declin y/i sale constrain open territori germani gross
margin declin pt y/i although beat estim bp
oper expens estim due
higher surgeon educ spend greater advertis market spend
increas sale forc hire
guidanc unchang hire progress well revenu guidanc
y/i growth left unchang prior quarter
geograph intern revenu like lighter origin anticip
european weak persist despit invest improv
commerci infrastructur model impli flat intern revenu q/q
germani constraint persist season occur
revenu vs prior offset continu momentum traction
us model revenu vs prior si-bon
end direct sale rep clinic support specialist track
slightli ahead expect new rep hire new clinic
support specialist expect hire remain strong throughout
drive acceler surgeon train also remain
strong manag suggest train program date well
attend consist prior quarter see manag confid
increas number activ surgeon vs
remain confid compani abil deliv y/i growth
base strong hire trend materi surgeon train
program expand awar si joint fusion increment payor
ifus bedrock could prove expans follow introduct
ifus bedrock techniqu adult deform aao receiv expand
medic technolog unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
fda clearanc april includ long construct procedur market
opportun estim procedur annual involv
fusion sacrum broader us launch product began june
manag encourag surgeon academ interest thu
far modest revenu contribut occur manag reiter
goal help expand awar si joint pain creat trickle-down
effect drive procedur growth see initi detail
convers suggest key focu compani year nass
meet late septemb discuss
catalyst rich discuss expect variou catalyst
provid opportun drive revenu multipl higher ifus
data submit public earlier summer target public
come month may catalyz larger payor re-review polici
mi sijf larger payor choos cover ifus procedur
see expand si-bon total cover live although propos
physician payment rate incorpor increas code
see languag year feder regist suggest stakehold
suggest rvu in-lin open sijf may appropri
although propos maintain rvu payment rate
essenti constant vs last year organ solicit public
comment set releas final rate novemb although
guidanc incorpor chang rate final compani
host surgeon event nass late septemb manag
also note sever event incorpor and/or relev ifus
bedrock look forward advanc discuss deform
opportun year meet see initi coverag broader
discuss deform
eye remain overweight similar preview result
break new ground acceler inflect remain stori
remain comfort compani abil deliv y/i growth
base expand sale forc hire contribut meaning
continu focu surgeon educ train effort expand
awar increment payor coverag decis
incorpor current guidanc recent launch ifus bedrock
incorpor model remain overweight price
target base dcf valuat impli revenu
price target base dcf valuat
similar spine compar price target impli
multipl base case sale premium core
spine compar given outsiz growth slight discount high
growth smid cap devic compani given acceler busi
yet proven
si-bon abl gain posit coverag decis larg commerci
payor develop addit exclus contract physician reimburs
doubl level compar open si joint fusion drive adopt
procedur growth faster anticip si-bon achiev market
penetr revenu
si-bon abl gradual expand commerci reimburs coverag
sale forc built earli physician reimburs rate rise
sale forc ramp allow broader physician awar procedur
adopt growth acceler model sale
reach
si-bon unsuccess gener addit coverag commerci
payor market adopt growth stall due physician reimburs
remain depress rel procedur price pressur
intensifi due increas competit achiev market
penetr
advantag penetr underserv
sacroiliac joint fusion market
differenti surgic implant ifus
implant random control studi
busi near point inflect
given momentum reimburs
landscap ii continu focu surgeon
educ iii sale forc expans
contribut meaning
addit pt penetr drive
pt growth
traction commerci payor present
opportun expand cover live
attract gross margin profil
expans patient identif
opportun deform trauma
potenti chang surgeon
reimburs level code
updat coverag polici addit
expand exclus contract ifus
risk achiev price
inabl gain addit reimburs
coverag commerci payor
si joint fusion market develop
expect oper small nich
limit visibl pipelin effort
million except ep
properti plant equip net
chang allow doubt account
chang fair valu conv prefer warrant
write-off pp
amort debt discount
chang work capit
oper
invest
proce stock option exercis
financ
effect foreign exchang rate
